Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Moderna shares fell 2.8% to close at $51.81 on Wednesday.Moderna, Inc. (NASDAQ:MRNA) will release earnings results for its third quarter, before the opening bell on Thursday, Nov. 7.
moderna公司（纳斯达克股票代码：MRNA）将于11月7日周四开盘前公布第三季度盈利结果。
Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at $1.9 per share, versus a year-ago loss of $9.53 per share. Moderna projects to report revenue of $1.25 billion for the quarter, compared to $1.83 billion a year earlier, according to data from Benzinga Pro.
分析师预计总部位于马萨诸塞州剑桥的公司将报告每股1.9美元的季度亏损，而去年同期为每股9.53美元。根据彭博智商数据，Moderna计划报告该季度12.5亿美元的营业收入，而去年同期为18.3亿美元。
On Oct. 28, On Monday, Merck & Co Inc (NYSE:MRK) and Moderna announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157).
10月28日，星期一，默沙东（纽交所股票代码：MRK）和moderna宣布启动V940（mRNA-4157）的重要3期试验INTerpath-009。
Moderna shares fell 2.8% to close at $51.81 on Wednesday.
moderna股价于周三下跌2.8%，收于51.81美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga读者可以在分析师股票评级页面上查看最新的分析师评级。读者可以按股票代码、公司名称、分析机构、评级变动或其他变量进行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
让我们来看看Benzinga最准确的分析师们是如何在最近一段时间内评价这家公司的。
- JP Morgan analyst Jessica Fye maintained an Underweight rating and cut the price target from $70 to $59 on Oct. 4. This analyst has an accuracy rate of 61%.
- Jefferies analyst Michael Yee maintained a Hold rating and slashed the price target from $65 to $55 on Oct. 15. This analyst has an accuracy rate of 63%.
- B of A Securities analyst Geoff Meacham maintained a Neutral rating and cut the price target from $130 to $110 on Sept. 13. This analyst has an accuracy rate of 60%.
- Needham analyst Joseph Stringer reiterated a Hold rating on Sept. 13. This analyst has an accuracy rate of 77%.
- Evercore ISI Group analyst Cory Kasimov maintained an In-Line rating with a price target of $120 on June 27. This analyst has an accuracy rate of 70%.
- JP摩根分析师Jessica Fye保持了减持评级，并于10月4日将目标价从70万亿美元下调至59美元。该分析师准确率为61%。
- Jefferies分析师Michael Yee保持了持有评级，并于10月15日将目标价从65万亿美元下调至55美元。该分析师准确率为63%。
- 美洲银行证券分析师Geoff Meacham维持中立评级，将价格目标从130万亿美元下调至110美元，时间为9月13日。该分析师的准确率为60%。
- Needham分析师Joseph Stringer于9月13日重申持有评级。该分析师的准确率为77%。
- Evercore ISI Group分析师Cory Kasimov于6月27日维持业绩一般评级，目标价为120美元。该分析师的准确率为70%。
Considering buying MRNA stock? Here's what analysts think:
考虑购买moderna股票吗？以下是分析师的看法：
Read This Next:
Read This Next:
- Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom
- 吉姆·克莱默：这家金融股值得买入，喜欢博通
